The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU

Peking University

Status: Enrolling

Conditions: Acute Kidney Injury; Intensive Care Unit; Ultrasound

Treatments: Other: Renal microcirculation quantitatively assessed by Contrast-enhanced ultrasound

Study type: Observational

Funder types: Other

Identifiers

NCT06341062

M2024078

Details and patient eligibility

About

The goal of this study is to quantitatively assess renal microcirculation changes by contrast-enhanced ultrasound and to obtain systemic hemodynamic information by ultrasound Doppler at the same time, to analyze the relationship between renal microcirculation changes and systemic hemodynamic changes, and to explore its predictive value in renal function recovery in patients with critical acute kidney injury. The main questions it aims to answer are:

1. To explore the quantitative parameters of contrast-enhanced ultrasound which can reflect the changes of renal microcirculation.
2. To explore the relationship between renal microcirculation and systemic hemodynamics.
3. To explore the value of renal microflow changes quantitatively evaluated by contrast-enhanced ultrasound in predicting renal function recovery.

Full description

Quantitative analysis of cortical perfusion by contrast-enhanced ultrasound； Echocardiography； Quantitative results of renal artery and vein spectrum

Enrollment: 44 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age >18 years old;
• AKI was diagnosed < 24 hours after first admission to intensive care unit (ICU) and the expected length of stay in ICU ≥48 hours;
• Meet Kidney Disease Improving Global Outcomes (KDIGO) 2012 diagnostic criteria for acute kidney injury;
• Contrast-enhanced ultrasound was performed within 24 hours after diagnosis of acute kidney injury (AKI).

Exclusion criteria

• Known severe chronic kidney disease (CKD≥ stage 4) or undergoing hemodialysis treatment;
• Kidney transplantation or renal malignancy;
• Terminal stage of malignant tumor;
• Pregnancy;
• Renal artery stenosis or renal vein thrombosis;
• Allergy to contrast agent SonoVue(BraccoSpA, Milan, Italy) or its components, or the presence of severe cardiopulmonary insufficiency (e.g., right-to-left shunt heart disease or pulmonary systolic blood pressure >90mmHg).

Trial design

44 participants in 2 patient groups

Patients recovering before hospital discharge

Description:

Recovery is defined as a return to normal serum creatinine and urine volume or more than 50% improvement in serum creatinine and/or urine volume from baseline

Patients not recovering before hospital discharge

Description:

Non-recovery is defined as no significant improvement or further increase in serum creatinine and/or urine volume, the need for dialysis, or death.

Treatment:

Other: Renal microcirculation quantitatively assessed by Contrast-enhanced ultrasound